AAFA's Advocacy for Health Equity Leads to White House Address on Asthma Inhaler Pricing
03 avr. 2024 14h45 HE
|
Asthma and Allergy Foundation of America
Washington, DC, April 03, 2024 (GLOBE NEWSWIRE) -- As the leading advocacy organization focused on improving the access and affordability of asthma inhalers, the Asthma and Allergy Foundation of...
AAFA Statement on Asthma Inhaler Price Caps
08 mars 2024 08h53 HE
|
Asthma and Allergy Foundation of America
Washington, DC, March 08, 2024 (GLOBE NEWSWIRE) -- The Asthma and Allergy Foundation of America (AAFA) is leading advocacy efforts to change the drug pricing ecosystem and to make medicines more...
![15-1493 Inside Look A Call for Rx Transparency Type Treatment3](http://www.globenewswire.com/fr/Attachment/LogoDisplay/358232?filename=358232.jpg&size=2)
Health Insurer Calls for Rx Transparency
23 sept. 2015 16h03 HE
|
Capital District Physicians' Health Plan, Inc.
ALBANY, N.Y., Sept. 23, 2015 (GLOBE NEWSWIRE) -- An Albany, NY-based health insurer has asked the pharmaceutical industry to "show me the money." CDPHP today called for price transparency and cost...
Pharmacy Benefit Management Institute Expands Content of 16th Annual Drug Benefit Design Survey
18 mars 2010 14h27 HE
|
Pharmacy Benefit Management Institute
SCOTTSDALE, AZ--(Marketwire - March 18, 2010) - The Pharmacy Benefit Management Institute (PBMI) is expanding the scope of its benefits research on prescription drug costs and plan design to...
Employers Effectively Controlling Drug Benefit Costs
07 oct. 2009 12h29 HE
|
Pharmacy Benefit Management Institute, LP (PBMI)
SCOTTSDALE, AZ--(Marketwire - October 7, 2009) - Employers are effectively controlling drug
benefit costs and utilization, according to research findings in the Pharmacy Benefit Management...
Pharmacy Benefit Management Institute Expands Content of 15th Annual Drug Benefit Design Survey
05 mai 2009 09h30 HE
|
Pharmacy Benefit Management Institute (PBMI)
SCOTTSDALE, AZ--(Marketwire - May 5, 2009) - The Pharmacy
Benefit Management Institute (PBMI) is expanding the scope of its
legacy study on prescription costs and
drug benefit plan design to...